News

EcoSyn Lite covers 10 MHz to 20 GHz frequency range and delivers +18 dBm output power. Housed in a portable, compact 4 inch x ...
Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, ...
It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...
Introduction Postoperative nausea and vomiting (PONV) is a common complication following various surgical procedures, ...
The stability of fixed-speed induction generator (FSIG)-based wind turbines can be improved by a StatCom, which is well known and documented in the literature for balanced grid voltage dips. Under ...